Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV‑1 envelope protein gp120 is an essential surface-exposed glycoprotein that orchestrates virus attachment to host cells through specific interactions with CD4 receptors followed by chemokine co-receptors. Its complex structure—characterized by high variability, extensive glycosylation, dynamic conformation shifts—and critical role in immune evasion make it both central to HIV pathogenesis and an important therapeutic/vaccine target.
Inhibition of gp120 interaction with CD4 or co-receptors, blocking viral entry
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Envelope Protein gp120 (gp120).